US Patent Issued to MINDRANK AI on Dec. 16 for "Aryl ether-substituted heterocyclic compounds as GLP1R agonists" (Chinese Inventors)

ALEXANDRIA, Va., Dec. 16 -- United States Patent no. 12,497,384, issued on Dec. 16, was assigned to MINDRANK AI LTD. (Hangzhou, China).

"Aryl ether-substituted heterocyclic compounds as GLP1R agonists" was invented by Long Zhang (Zhejiang, China), Zhangming Niu (Zhejiang, China) and Bowen Tang (Zhejiang, China).

According to the abstract* released by the U.S. Patent & Trademark Office: "The present invention relates to a novel aryl ether substituted heterocyclic compound having GLP1R agonist activity. Specifically, disclosed are a compound as a GLP1R agonist represented by formula (1), or a pharmaceutically acceptable salt, solvate, hydrate, isotope substituent or isomer thereof."

The patent was filed on May 23, 2025, under Application N...